<html>
<head>PUBMED IDs for TOP3A</head>
<body bgcolor='#C5F0F2'><h1>TOP3A</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12550767/'>Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma.</a> January 29  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/19432957/'>Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study.</a> July 8  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20623552/'>Developing T lymphocytes are uniquely sensitive to a lack of topoisomerase III alpha.</a> November 4  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22050635/'>TOP3A, a new partner gene fused to MLL in an adult patient with de novo acute myeloid leukaemia.</a> March 26  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22102081/'>Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor.</a> July 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22102073/'>135G&gt;C and 172G&gt;T polymorphism in the 5' untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women.</a> February 24  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22292074/'>Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.</a> June 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/27846620/'>Oncogenic Properties of Candidate Oncogenes in Chromosome Region 17p11.2p12 in Human Osteosarcoma.</a> November 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27846595/'>Precaution and governance of emerging technologies.</a> June 27  2016<br></body></html>
